Study investigated skin-related adverse events in patients with Adult T-cell lymphoma treated with mogamulizumab.
Home / Resource Library / Mogamulizumab Treatment Elicits Autoantibodies Attacking the Skin in Patients with Adult T-Cell Leukemia-Lymphoma